 Richard Allen
Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 13 | 2015 | 162 | 3.280 |
Why?
| | Cocaine-Related Disorders | 7 | 2014 | 133 | 1.500 |
Why?
| | Motor Activity | 7 | 2013 | 718 | 1.270 |
Why?
| | Reinforcement Schedule | 7 | 2014 | 25 | 1.220 |
Why?
| | Excitatory Amino Acid Antagonists | 5 | 2014 | 108 | 1.010 |
Why?
| | Isoquinolines | 5 | 2007 | 43 | 0.970 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 6 | 2014 | 229 | 0.960 |
Why?
| | Dizocilpine Maleate | 4 | 2014 | 24 | 0.930 |
Why?
| | Self Administration | 9 | 2015 | 122 | 0.910 |
Why?
| | Dopamine Uptake Inhibitors | 3 | 2013 | 59 | 0.870 |
Why?
| | Conditioning, Operant | 6 | 2013 | 94 | 0.790 |
Why?
| | Rats, Sprague-Dawley | 12 | 2014 | 2525 | 0.550 |
Why?
| | Rats | 15 | 2017 | 5585 | 0.540 |
Why?
| | Motivation | 2 | 2012 | 602 | 0.460 |
Why?
| | Corpus Striatum | 2 | 2013 | 179 | 0.430 |
Why?
| | Behavior, Addictive | 2 | 2013 | 88 | 0.430 |
Why?
| | Individuality | 4 | 2012 | 149 | 0.400 |
Why?
| | Receptor, Metabotropic Glutamate 5 | 1 | 2013 | 5 | 0.400 |
Why?
| | Dose-Response Relationship, Drug | 9 | 2013 | 2028 | 0.390 |
Why?
| | Morphine | 3 | 2003 | 169 | 0.350 |
Why?
| | Receptors, Opioid, mu | 2 | 2003 | 66 | 0.230 |
Why?
| | Dextromethorphan | 2 | 2005 | 24 | 0.230 |
Why?
| | Animals | 18 | 2017 | 38106 | 0.230 |
Why?
| | Benzamides | 2 | 2002 | 226 | 0.200 |
Why?
| | Infusions, Intravenous | 3 | 2011 | 428 | 0.200 |
Why?
| | Receptors, Opioid, delta | 2 | 2002 | 10 | 0.190 |
Why?
| | Analysis of Variance | 3 | 2013 | 1300 | 0.190 |
Why?
| | Behavior, Animal | 4 | 2017 | 520 | 0.180 |
Why?
| | Piperazines | 2 | 2002 | 375 | 0.180 |
Why?
| | Antitussive Agents | 1 | 2002 | 7 | 0.180 |
Why?
| | Male | 16 | 2017 | 73012 | 0.150 |
Why?
| | Extinction, Psychological | 2 | 2013 | 92 | 0.150 |
Why?
| | Reaction Time | 2 | 2014 | 434 | 0.140 |
Why?
| | Pain | 1 | 2003 | 791 | 0.130 |
Why?
| | Consummatory Behavior | 1 | 2017 | 3 | 0.130 |
Why?
| | Saimiri | 4 | 2004 | 11 | 0.120 |
Why?
| | Quantitative Trait Loci | 1 | 2017 | 381 | 0.110 |
Why?
| | Infusions, Subcutaneous | 1 | 2014 | 23 | 0.110 |
Why?
| | Locomotion | 1 | 2015 | 101 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2002 | 1154 | 0.090 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2013 | 59 | 0.090 |
Why?
| | Ethanol | 1 | 2017 | 631 | 0.090 |
Why?
| | Drug Synergism | 2 | 2003 | 354 | 0.090 |
Why?
| | Injections, Intraperitoneal | 2 | 2008 | 116 | 0.080 |
Why?
| | Alcoholism | 1 | 2017 | 826 | 0.080 |
Why?
| | Alcohol Drinking | 1 | 2017 | 843 | 0.080 |
Why?
| | Causality | 1 | 2008 | 127 | 0.070 |
Why?
| | Injections, Intraventricular | 1 | 2007 | 59 | 0.070 |
Why?
| | Neurotransmitter Agents | 1 | 2007 | 84 | 0.060 |
Why?
| | Central Nervous System Stimulants | 1 | 2008 | 185 | 0.060 |
Why?
| | Narcotics | 2 | 2003 | 58 | 0.060 |
Why?
| | Catheterization, Peripheral | 1 | 2007 | 120 | 0.060 |
Why?
| | N-Methylaspartate | 1 | 2005 | 43 | 0.060 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 368 | 0.060 |
Why?
| | Time Factors | 2 | 2015 | 7134 | 0.060 |
Why?
| | Electroshock | 2 | 2002 | 146 | 0.050 |
Why?
| | Receptors, Opioid, kappa | 1 | 2004 | 9 | 0.050 |
Why?
| | Tetrahydroisoquinolines | 1 | 2004 | 8 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 782 | 0.050 |
Why?
| | Glutamic Acid | 1 | 2007 | 255 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2601 | 0.050 |
Why?
| | Levorphanol | 1 | 2003 | 2 | 0.050 |
Why?
| | Software | 1 | 2008 | 680 | 0.050 |
Why?
| | Piperidines | 1 | 2004 | 222 | 0.050 |
Why?
| | Narcotic Antagonists | 1 | 2004 | 203 | 0.040 |
Why?
| | Pyrrolidinones | 1 | 2002 | 29 | 0.040 |
Why?
| | Analgesics | 1 | 2002 | 231 | 0.040 |
Why?
| | Pain Measurement | 1 | 2002 | 562 | 0.040 |
Why?
| | Animals, Congenic | 1 | 2017 | 9 | 0.030 |
Why?
| | Species Specificity | 1 | 2017 | 546 | 0.030 |
Why?
| | Phenotype | 1 | 2017 | 3170 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2399 | 0.020 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 113 | 0.010 |
Why?
| | Time | 1 | 2004 | 84 | 0.010 |
Why?
| | Butorphanol | 1 | 2002 | 3 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2013 | 4568 | 0.010 |
Why?
| | Drug Interactions | 1 | 2002 | 405 | 0.010 |
Why?
| | Buprenorphine | 1 | 2002 | 192 | 0.010 |
Why?
| | Protein Binding | 1 | 2004 | 2240 | 0.010 |
Why?
| | Mice | 1 | 2004 | 18358 | 0.000 |
Why?
| | Female | 1 | 2008 | 79045 | 0.000 |
Why?
| | Humans | 1 | 2004 | 145785 | 0.000 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|